Solvias is a world leader in contract research, development and manufacturing. The industries we serve include pharmaceuticals, biotech, medical devices and cosmetics.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

PROTECT PHARMACEUTICAL CORPORATION HAS ACQUIRED TOP NOTCH SOFTWARE DEVELOPMENT COMPANY.

PROTECT PHARMACEUTICAL Corp | June 28, 2022

news image

Protect Pharmaceutical Corporation has acquired the 100% of the shares of CJSC “Inaiapp”, a Belarusian developer of corporate software for business digitalization. With 8 years of blockchain development experience and list of long term clients, Inaiapp will bring its qualification and management processes to a new level. “Robotic process automation, AI systems and machine learning systems, blockchain-based solutions, Data Scie...

Read More

Business Insights

SPOTLIGHT THERAPEUTICS APPOINTS VISIONARY GLOBAL PHARMA DRUG DEVELOPER ANTOINE YVER, M.D., M.SC. AS FIRST INDEPENDENT BOARD MEMBER

Spotlight Therapeutics | July 18, 2022

news image

Spotlight Therapeutics, Inc. a biotechnology company applying new insights to develop cell-targeted in vivo CRISPR gene editing biologics, announced the appointment of Antoine Yver, M.D., M.Sc. to the Spotlight Board of Directors. Trained as an oncologist and immunologist, Dr. Yver’s extensive industry experience and perceptive acumen will be extremely valuable as Spotlight continues to strengthen its highly differentiated TAGE platform and advance lead therapeutic candidates towards the c...

Read More

Business Insights, PHARMACY MARKET

MASSIVE BIO AND NEOGENOMICS ANNOUNCE COLLABORATION TO ACCELERATE ONCOLOGY DRUG DISCOVERY AND IMPROVE PATIENT CARE

Businesswire | March 27, 2023

news image

Massive Bio, Inc., a private AI-enabled oncology startup that provides virtual and in-person concierge services for cancer patients, and NeoGenomics, Inc. a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced a collaboration with the goal of accelerating the development of new cancer therapies and ultimately improving the lives of millions of cancer patients around the world. NeoGenomics will identify patients in real ...

Read More

Business Insights, PHARMA TECH

CLINCHOICE ANNOUNCES ACQUISITION OF CROMSOURCE

ClinChoice | March 03, 2023

news image

ClinChoice, a leading global clinical CRO, recently announced that it has acquired CROMSOURCE S.r.l., an ISO-certified full-service contract research organization. CROMSOURCE has its corporate headquarters in Verona, Italy, its US headquarters in Cary, NC, and subsidiaries in the US and seven countries throughout eastern and western Europe. With a proven track record of providing excellent clinical research and staffing services to multinational pharmaceutical, biotechnology, an...

Read More
news image

Business Insights

PROTECT PHARMACEUTICAL CORPORATION HAS ACQUIRED TOP NOTCH SOFTWARE DEVELOPMENT COMPANY.

PROTECT PHARMACEUTICAL Corp | June 28, 2022

Protect Pharmaceutical Corporation has acquired the 100% of the shares of CJSC “Inaiapp”, a Belarusian developer of corporate software for business digitalization. With 8 years of blockchain development experience and list of long term clients, Inaiapp will bring its qualification and management processes to a new level. “Robotic process automation, AI systems and machine learning systems, blockchain-based solutions, Data Scie...

Read More
news image

Business Insights

SPOTLIGHT THERAPEUTICS APPOINTS VISIONARY GLOBAL PHARMA DRUG DEVELOPER ANTOINE YVER, M.D., M.SC. AS FIRST INDEPENDENT BOARD MEMBER

Spotlight Therapeutics | July 18, 2022

Spotlight Therapeutics, Inc. a biotechnology company applying new insights to develop cell-targeted in vivo CRISPR gene editing biologics, announced the appointment of Antoine Yver, M.D., M.Sc. to the Spotlight Board of Directors. Trained as an oncologist and immunologist, Dr. Yver’s extensive industry experience and perceptive acumen will be extremely valuable as Spotlight continues to strengthen its highly differentiated TAGE platform and advance lead therapeutic candidates towards the c...

Read More
news image

Business Insights, PHARMACY MARKET

MASSIVE BIO AND NEOGENOMICS ANNOUNCE COLLABORATION TO ACCELERATE ONCOLOGY DRUG DISCOVERY AND IMPROVE PATIENT CARE

Businesswire | March 27, 2023

Massive Bio, Inc., a private AI-enabled oncology startup that provides virtual and in-person concierge services for cancer patients, and NeoGenomics, Inc. a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced a collaboration with the goal of accelerating the development of new cancer therapies and ultimately improving the lives of millions of cancer patients around the world. NeoGenomics will identify patients in real ...

Read More
news image

Business Insights, PHARMA TECH

CLINCHOICE ANNOUNCES ACQUISITION OF CROMSOURCE

ClinChoice | March 03, 2023

ClinChoice, a leading global clinical CRO, recently announced that it has acquired CROMSOURCE S.r.l., an ISO-certified full-service contract research organization. CROMSOURCE has its corporate headquarters in Verona, Italy, its US headquarters in Cary, NC, and subsidiaries in the US and seven countries throughout eastern and western Europe. With a proven track record of providing excellent clinical research and staffing services to multinational pharmaceutical, biotechnology, an...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us